Reversed-Phase High-Performance Liquid Chromatography Determination of Cyclosporin in Human Blood
- 1 September 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 9 (3) , 353-357
- https://doi.org/10.1097/00007691-198709000-00017
Abstract
A high-performance liquid chromatographic (HPLC) method for determination of cyclosporin A (CyA) in blood, using cyclosporin D (CyD) as internal standard, is described. The method is specific, precise, reproducible, accurate, and isocratic, and it requires no derivatization. It is more rapid than previously described methods. Its detection limit is 25 ng/ml, suitable for quantitation of the drug at clinically observed concentrations. No interference was found by any of the other commonly coadministered drugs tested. Comparison of measurements in patients' blood with radioimmunoassay (RIA) results showed lower estimates by the chromatographic technique. Because measurements of the drug in blood blanks spiked with pure CyA were similar with the two techniques, the nonspecificity of RIA, probably related to cyclosporin metabolites, was demonstrated. Because the chromatographic technique is simple, it should be preferred to RIA in therapeutic drug monitoring.Keywords
This publication has 8 references indexed in Scilit:
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- PHARMACOKINETICS AND NEPHROTOXICITY OF CYCLOSPORINE IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1985
- CLINICAL HEART-LUNG TRANSPLANTATIONTransplantation, 1984
- CYCLOSPORINE IN HUMAN BONE MARROW TRANSPLANTATION SEKUM CONCENTRATION, GRAFT-VERSUS-HOST DISEASE, AND NEPHROTOXICITYTransplantation, 1983
- Intraindividual variation in drug dispositionClinical Pharmacology & Therapeutics, 1979
- CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MANThe Lancet, 1978
- EFFECTS OF NEW ANTI-LYMPHOCYTIC PEPTIDE CYCLOSPORIN-A IN ANIMALS1977
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976